OSLO, Norway--(BUSINESS WIRE)--Regulatory News:
DiaGenic’s (OSE:DIAG) blood sample based Alzheimer’s disease test has proven successful in a clinical study released today. DiaGenic is the first to diagnose Alzheimer’s disease from a blood sample at such an early stage of the disease.
